$2.77
0.26[10.36%]
Last update: 9:28AM Get Real Time Here
Immutep
(NASDAQ:IMMP)Latest News for Immutep Stock (NASDAQ:IMMP)
Immutep Stock (NASDAQ: IMMP)
Categories: All
Wednesday, April 24, 2024
- Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday?Vandana Singh - 44 minutes ago
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - 3 hours ago
- Immutep shares are trading higher after the company announced data evaluating efti with KEYTRUDA in recurrent/metastatic head and neck squamous cell carcinoma patients.Benzinga Newsdesk - 3 hours ago
- Immutep Announced Tuesday, Data From Efti In Combination With Keytruda In First Line Head And Neck Squamous Cell Carcinoma Patients Who Do Not Express PD-L1 Shows A Preliminary 26.9% Response Rate, The Primary Endpoint Of The StudyCharles Gross - 5 hours ago
Thursday, April 18, 2024
Wednesday, April 17, 2024
Tuesday, March 05, 2024
Tuesday, January 30, 2024
Thursday, January 04, 2024
Thursday, December 07, 2023
Wednesday, December 06, 2023
Wednesday, November 22, 2023
Thursday, November 09, 2023
Monday, November 06, 2023
Tuesday, October 31, 2023
Wednesday, October 25, 2023
Tuesday, October 24, 2023
Monday, October 23, 2023
Sunday, October 22, 2023
Thursday, September 21, 2023
Monday, August 28, 2023
Thursday, August 03, 2023
Wednesday, August 02, 2023
Tuesday, August 01, 2023
Monday, July 31, 2023
- Immutep's Cash And Cash Equivalent Balance As At 30 June 2023 Was ~$123.4MHappy Mohamed - Jul 31, 2023, 8:12AM
- Immutep Announced Earlier It Will Present Overall Survival Data In1st Line Non-Small Cell Lung Cancer Accepted for Oral Presentation At ESMO Congress 2023Charles Gross - Jul 31, 2023, 4:48AM
Friday, July 28, 2023
Tuesday, June 27, 2023
Tuesday, June 20, 2023
Monday, June 05, 2023
Wednesday, May 31, 2023
Tuesday, May 30, 2023
Monday, May 29, 2023
Friday, May 26, 2023
Thursday, May 25, 2023
Wednesday, May 24, 2023
- Immutep Limited shares are trading higher after the company announced new clinical data from triple combination therapy in INSIGHT-003 trial.Benzinga Newsdesk - May 24, 2023, 12:54PM
- Immutep Touts Encouraging Data From Efti Triple Combination Therapy In Lung Cancer SettingVandana Singh - May 24, 2023, 12:49PM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - May 24, 2023, 9:06AM
- Immutep Announces New Clinical Data from Triple Combination Therapy in INSIGHT-003 TrialBenzinga Newsdesk - May 24, 2023, 8:02AM